Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Times Interest Earned (2020 - 2026)

Journey Medical filings provide 6 years of Times Interest Earned readings, the most recent being $5.72 for Q4 2025.

  • On a quarterly basis, Times Interest Earned rose 112.94% to $5.72 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.65, a 87.25% increase, with the full-year FY2025 number at -$0.65, up 87.25% from a year prior.
  • Times Interest Earned hit $5.72 in Q4 2025 for Journey Medical, up from -$1.63 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $64.35 in Q3 2023 to a low of -$87.67 in Q4 2023.
  • Median Times Interest Earned over the past 5 years was -$4.51 (2024), compared with a mean of -$7.29.
  • Biggest five-year swings in Times Interest Earned: tumbled 820.65% in 2021 and later soared 478.95% in 2023.
  • Journey Medical's Times Interest Earned stood at -$2.21 in 2021, then tumbled by 632.97% to -$16.2 in 2022, then tumbled by 441.17% to -$87.67 in 2023, then soared by 103.07% to $2.69 in 2024, then surged by 112.94% to $5.72 in 2025.
  • The last three reported values for Times Interest Earned were $5.72 (Q4 2025), -$1.63 (Q3 2025), and -$3.07 (Q2 2025) per Business Quant data.